Selegiline/phosphodiesterase-5 inhibitor
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameSelegiline/phosphodiesterase-5 inhibitor
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSagene Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesSagene Pharmaceuticals
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A